Eli Lilly’s Valuation Has Changed. Here’s What Investors Need to Know

Eli Lilly and Company (NYSE:LLY) has carved out a strong position in the pharmaceutical industry, with much of its competitive advantage now tied to its leadership in diabetes and obesity treatments. The company’s moat comes from several factors working together: drug innovation, patent protection, manufacturing capacity, brand strength, and a deep pipeline of new treatments. […]